title: Isoniazid treatment of children: can genetics help guide treatment?
authors.affiliation: Royal Children's Hospital and Murdoch Children's Research Institute, University of Melbourne, Australia.
authors.forename: N
authors.initials: N
authors.lastname: Cranswick
authors.forename: K
authors.initials: K
authors.lastname: Mulholland
mesh_terms: D000367:Age Factors; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002648:Child; D004334:Drug Administration Schedule; D005838:Genotype; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010597:Pharmacogenetics; D014376:Tuberculosis / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid